Abstract
Obesity hypoventilation syndrome (ΟHS) has increased in recent decades because of the increasing prevalence of obesity. Early diagnosis is essential because these patients suffer from poor quality of life and severe comorbidities. Further examinations must be conducted to exclude other diseases that also cause hypoventilation. A polysomnography is often necessary to determine the form of sleep-disordered breathing (obstructive or non-obstructive) and individualize the treatment mode. CPAP is the first step in the treatment of patients with OHS who also suffer from severe OSA (AHI ≥ 30). NIV is usually chosen when response to previous CPAP treatment is inadequate or in cases where there is mainly nocturnal hypoventilation without severe OSA (ΑΗΙ < 30). It is also used in obese patients with acute-on-chronic respiratory failure. AVAPS mode should be applied when the treatment with other PAP modalities has failed. Oxygen therapy should be added when needed, but never as a monotherapy. NIV is well documented to treat nocturnal hypoventilation and OSA if it co-exists, daytime hypercapnia, TST < 90%, quality of sleep, gas exchange, hospital admissions, and quality of life. It also prevents severe complications such as cardiovascular diseases. Consequently, early application is essential to reduce mortality and morbidity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sturm R. Increases in clinically severe obesity in the United States, 1986–2000. Arch Intern Med. 2003;163:2146–8.
Mokhlesi B. Obesity hypoventilation syndrome a state-of-the-art review. Respir Care. 2010;55(10):1347–65.
Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007;11(2):117.
Macavei VM, Spurling KJ, Loft J, Makker HK. Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med. 2013;9(9):879–84.
Akashiba T, Akahoshi T, Kawahara S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med. 2006;45:1121–5.
Masa JF, Pépin JL, Borel JC, Mokhlesi B, Murphy PB, Sánchez-Quiroga MÁ. Obesity hypoventilation syndrome. Eur Respir Rev. 2019;28(151):180097.
Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc. 2008;5:218–25.
Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and management of obesity hypoventilation syndrome. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2019;200(3):6–24.
Masa JF, Corral J, Alonso ML, Ordax E, et al. Efficacy of different treatment alternatives for obesity hypoventilation syndrome. Pickwick study. Am J Respir Crit Care Med. 2015;192:86–95.
Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med. 2012;8:597–619.
Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. The total work of breathing in normal and obese men. J Clin Invest. 1964;43:728–39.
Zavorsky GS, Hoffman SL. Pulmonary gas exchange in the morbidly obese. Obes Rev. 2008;9:326–39.
Piper AJ, Grunstein RR. Obesity hypoventilation syndrome mechanisms and management. Am J Respir Crit Care Med. 2011;183:292–8.
Kessler R, Chaouat A, Schinkewitch P, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest. 2001;120:369–76.
Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis. 1983;128:177–81.
Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395–401.
Mokhlesi B, Tulaimat A, Evans AT, et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med. 2006;2(1):57–62.
Steier J, Jolley CJ, Seymour J, et al. Neural respiratory drive in obesity. Thorax. 2009;64(8):719–25.
Hida W, Okabe S, Tatsumi K, et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath. 2004;7(1):3–12.
Borel JC, Tamisier R, Gonzalez-Bermejo J, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141(3):692–702.
Orfanos S, Jaffuel D, Perrin C, et al. Switch of noninvasive ventilation (NIV) to continuous positive airway pressure (CPAP) in patients with obesity hypoventilation syndrome: a pilot study. BMC Pulm Med. 2017;17(1):50.
Banerjee D, Yee BJ, Piper AJ, et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007;131(6):1678–84.
De Llano LAP, Golpe R, et al. Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications. Respiration. 2008;75(1):34–9.
Masa JF, Benítez I, Sánchez-Quiroga MÁ, et al. Long-term noninvasive ventilation in obesity hypoventilation syndrome without severe OSA. The pickwick randomized controlled trial. Chest. 2020;158(3):1176–86.
Masa JF, Corral J, Caballero C, et al. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea. Thorax. 2016;71(10):899–906.
Royer CP, Schweiger C, Manica D, et al. Efficacy of bilevel ventilatory support in the treatment of stable patients with obesity hypoventilation syndrome: systematic review and meta-analysis. Sleep Med. 2019;53:153–64.
Masa JF, Mokhlesi B, Benítez I, et al. Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome. Long-term pickwick randomized controlled clinical trial. Am J Respir Crit Care Med. 2020;201(5):586–97.
Álvarez RF, Ramire JB, Cuadrado GR, et al. Obesity-hypoventilation syndrome: baseline hemodynamic status and impact of non-invasive ventilation. Arch Bronconeumol. 2020;56(7):441–5.
Murphy PB, Davidson C, Hind MD, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomized controlled trial. Thorax. 2012;67:727–34.
Patout M, Gagnadoux F, Rabec C, et al. AVAPS-AE versus ST mode: a randomized controlled trial in patients with obesity hypoventilation syndrome. Respirology. 2020;25(10):1073–81.
Howard ME, Piper AJ, Stevens B, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax. 2017;72:437–44.
Masa JF, Mokhlesi B, Benítez I, de Terreros Caro FJG, et al. Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea. Thorax. 2020;75(6):459–67.
Soghier I, Brożek JL, Afshar M, et al. Noninvasive ventilation versus CPAP as initial treatment of obesity hypoventilation syndrome. Ann ATS. 2019;16(10):1295–303.
Marik PE, Desai H. Characteristics of patients with the “malignant obesity hypoventilation syndrome” admitted to an ICU. J Intensive Care Med. 2013;28(2):124–30.
Oliveros H, Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity. 2008;16(3):515–21.
Davidson AC, Banham S, Elliott M, et al. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016;71(Suppl 2):ii1–35.
Carrillo A, Ferrer M, Gonzalez-Diaz G, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:1279–85.
Lemyze M, Taufour P, Duhamel A, et al. Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS One. 2014;9(5):e97563.
Chebib N, Nesme P, Freymond N, Argaud L, Rimmelé T, Bohé J, et al. Acute respiratory failure in obesity-hypoventilation syndrome managed in the ICU. Respir Care. 2019;64(12):1545–54.
Nicolini A, Lemyze M, Esquinas, Barlascini C, Cavalleri MA. Predictors of noninvasive ventilation failure in critically ill obese patients: a brief narrative review. Adv Respir Med. 2017;85(5):264–70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Papathanasiou, M., Siopi, D. (2023). Noninvasive Ventilation in Patients with Obesity Hypoventilation Syndrome. In: Esquinas, A.M. (eds) Noninvasive Mechanical Ventilation. Springer, Cham. https://doi.org/10.1007/978-3-031-28963-7_28
Download citation
DOI: https://doi.org/10.1007/978-3-031-28963-7_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-28962-0
Online ISBN: 978-3-031-28963-7
eBook Packages: MedicineMedicine (R0)